EMA cGMP certification to Viralgen

The Viralgen receives the European Medicines Agency (EMA) cGMP compliance accreditation certificate and Spanish Agency for Medicines and Health Products (AEMPS) Pharmaceutical Laboratory authorization.

The organization is a leading contract development and manufacturing organization with expertise in the development, validation and manufacturing of adeno-associated virus gene therapies. Safety, efficacy, quality and information accuracy of health and medicinal products to manufacture processes in a manner to safeguard and promote health of individuals can be ensured through cGMP certification.

Robust and unique manufacturing platform is utilized by the Viralgen for the manufacturing of adeno-associated virus gene therapies at large scale.  The organization has three independent cGMP manufacturing locations for simultaneous and continuous development of three unique products.

The EMA cGMP certification confirms that commitment of Viralgen is working with high regulatory standards.